HRS-1893 - Jiangsu Hengrui Pharma
A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Jul 23, 2024 - P2 | N=42 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. 
New P2 trial • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
http://clinicaltrials.gov/ct2/show/NCT06516068
 
Jul 23, 2024
 
Prev Next